Natalizumab (NZM), a humanized monoclonal IgG4 antibody to ?4 integrins, is used to treat patients with relapsing-remitting multiple sclerosis (MS), but in about 6% of the cases persistent neutralizing anti-drug antibodies (ADAs) are induced leading to therapy discontinuation. To understand the basi...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606)